Neurobehavioral and psychological changes induced by hyperthyroidism: diagnostic and therapeutic implications

References

• Jadresic D. Psychiatric aspect of hyperthyroidism. I PTchosom. Res. 34, 603–615 (1990).
   PubMed Web of Science ®Google Scholar
• •This paper reviewed the course, outcome and implications for management of psychiatric disorders associated with hyperthyroidism.
   Google Scholar
• Whybrow P, Bauer M. Behavioral and psychiatric aspects of thyrotoxicosis. In: The Thyroid: A Fundamental and Clinical Text (Volume 48). Braverman L, Utiger R (Eds), Lippincott Williams & Wilkins, Philadelphia, USA, 673–678 (2000).
   Google Scholar
• Kessler RC, McGonagle IKA, Zha S. Lifetime and 12-month prevalence of DSM m-R psychiatric disorders in the United States: results from the National Comorbidity Study. Arch. Gen Psychiatry 345, 8–19 (1994).
   Google Scholar
• Vicente B, Rioseco P, Vielma M. Prevalencia de vida de algunos trastornos psiquidtricos en la provincia de Concepción. Rev. Fiiquiatria IX, 1050–1060 (1992).
   Google Scholar
• Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism. I. prevalence and clinical relevance. Nell?. J. Med. 46, 197–204 (1995).
   Google Scholar
• Woeber KA. Subclinical thyroid dysfunction. Arch. Intern. Med. 157, 1065–1068 (1997).
   PubMedGoogle Scholar
• Konno N, Yuri K, Taguchi H et al Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays and serum thyroid autoantibody and
   Google Scholar
• •• urinary iodide determinations. Clin. Endocrine" (0x1). 38,273-281 (1993).
   Google Scholar
• Fardella C, Poggi M, Gloger S et al. High prevalence of subclinical thyroidal disease among individuals attended in health control. Rev Med Chile 129,155–160 (2001).
   PubMed Web of Science ®Google Scholar
• Fava M, Labbate LA, Abraham ME, Rosenbaum JE Hypothyroidism and hyperthyroidism in major depression revisited.' Clin. PFhiatry56(5), 186–192 (1995).
   Google Scholar
• Woolf PD, Nichols D, Porsteinsson A, Boulay R. Thyroid evaluation of hospitalized psychiatric patients: the role of tsh screening for thyroid dysfunction. Thyroic16(5), 451–456 (1996).
   Google Scholar
• Fardella C, Gloger S, Figueroa R et al High prevalence of thyroid abnormalities in a Chilean psychiatric population Endocrine" Invest. 23,102-106 (2000).
   Google Scholar
• Fishman SM, Sheehan DV, Carr DB. Thyroid indices in panic disorder. j Clin. fiychiatry 46, 432–433 (1985).
   Google Scholar
• Roy-Byrne PP, Uhde TVV, Rubinow DR Post RM. Reduced TSH and prolactin response to TRH in patients with panic disorders. Am Psychiatry143,503–507 (1986).
   Google Scholar
• Roy-Byrne PP, Mellman TA, Uhde TVV. Neuroendocrine and sleep abnormalities in panic disorders. .1. Anxiety Disocrlers2,17–29 (1988).
   Google Scholar
• Matuzas W, Al-Sadir J, Uhlenhuth EH, Glass RM. Mitral valve prolapse and thyroid abnormalities in patients with panic attacks. Aim j Psychiatry 144,493–496 (1987).
   PubMedGoogle Scholar
• Checkley SA. Thyrotoxicosis and the course of maniac depressive illness. BE fiychiatry133,219–223 (1978).
   PubMedGoogle Scholar
• Parker PE, Walter Ryan WG, Folks DG. Lithium treatment of hyperthyroidism and mania.j Clin. PFhiatry47,264–266 (1986).
   PubMedGoogle Scholar
• Brownlie BE, Rae AM, Walshe JW, Wells JE. Psychoses associated with thyrotoxicosis-thyrotoxic psychosis'. A report of 18 cases, with statistical analysis of incidence. Eur. Endocrine" 142,438–444 (2000).
   Google Scholar
• •This paper reports a series of newly diagnosed thyrotoxic patients with concurrent acute psychosis and assess the associations between the disorders.
   Google Scholar
• Brenner I. Apathetic hyperthyroidism. Clin. Psychiat. 39,479–480 (1978).
   PubMedGoogle Scholar
• Fardella C, Lopez JM, Valdes ME, Nunez M, Miranda M. Autoimmune thyroid disease in the puerperium. Predictive value of thyroid enlargement and related hormonal changes occurring during pregnancy. I Endocrine'. Invest. 13,283–286 (1990).
   Google Scholar
• Harris B, Othman S, Davies J et al Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BE Med. 305,152–156 (1992).
   PubMed Web of Science ®Google Scholar
• Suresh P, Sebastian S, George A, Radhakrishnan. Subclinical hyperthyroidism and hyperkinetic behavior in children. Pediatr. Nur& 20,192–194 (1999).
   Google Scholar
• Weiss RE, Stein MA, Refetoff S. Behavioral effects of liothyronine (L-T3) in children with attention-deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone. ThyroicI7, 389–393 (1997).
   Google Scholar
• McGaffee J, Lippmann S, Barnes MA. Psychiatric presentations of hyperthyroidism. Am. Fain. Physician 27, 257–260 (1983).
   PubMedGoogle Scholar
• Nath J, Sagar R. Late-onset bipolar disorder due to hyperthyroidism. Acta P9rhiatc: Scan. 104,72-75 (2001).
   Google Scholar
• Corn TH, Checkley SA. A case of recurrent mania with recurrent hyperthyroidism. BE P9rhiatry143,74–76 (1983).
   Google Scholar
• Kalmijn S, Mehta K, Pols H, Hofman A, Drexhage H, Breteler M. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin. Endocrine" 53, 733–737 (2000).
   Google Scholar
• Kung AW. Life events, daily stresses and coping in patients with Graves Disease. Clin. Endocrine'. (0x1). 42,303-308 (1995).
   Google Scholar
• Radosavljevic VR, Jankovic SM, Marinkovic JM. Stressful life events in the pathogenesis of Graves disease. Eur. Endocrine'. 134,699–701 (1996).
   Google Scholar
• Harris T, Creed F, Brugha TS. Stressful life events and Graves disease. BE j Psychiaby 161,535–541 (1992).
   Google Scholar
• Winsa B, Adami H-0, Bergstrom R et al. A. Stressful life events and Graves disease. Lancet338, 1475–1479 (1991).
   Google Scholar
• Matsubayashi S, Tamai H, Matsumoto Y et al Graves disease after the onset of panic disorder. fiychother. Bychosom. 65(5), 277–280 (1996).
   Google Scholar
• Weller MP. Agoraphobia and hyperthyroidism. BE j Psychiatry 144, 553–554 (1984).
   PubMedGoogle Scholar
• Gloger S, Fardella C, Gajardo C et al. Panic disorder and hyperthyroidism. Report of two cases. Rev. Med Chile 129,187–190 (2001).
   PubMed Web of Science ®Google Scholar
• Voth HM, Holzman PS, Katz JB, Wallerstein RS. Thyroid hot spots: their relationship to life stress. P9rhosom. Med. 32,561-568 (1970).
   Google Scholar
• Friedman Y, Bacchus R, Raymond R, Joffe R, Nobrega J. Acute stress increases thyroid hormone levels in rat brain. Biel Psychiatry 45,234–237 (1999).
   Google Scholar
• Kiecolt-Glaser JK, Garner W, Speicher CE, Penn GM, Holliday J, Glaser R. Psychosocial modifier of immune competence in medical students. P9rhosom. Med 46,7–14 (1984).
   Google Scholar
• Gloger S, Puente J, Arias P et al Modifications in lymphocyte proliferation induced by academic stress in medical students. Rev Med. CM 125,665–670 (1997).
   PubMedGoogle Scholar
• De-Bellis MD, Burke L, Trickett PK, Putnam FW. Antinuclear antibodies and thyroid function in sexually abused girls. Trauma Stress 9 (2), 369–378 (1996) .
   PubMedGoogle Scholar
• Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed out-patients. Clin. PFhiatry58, 146–152 (1997)
   PubMed Web of Science ®Google Scholar
• Lambert MT, Trutia C, Petty E Extrapyramidal adverse effects associated with sertraline. fhg. Neuropsychopharmacel Biel fiychiatry22, 741–748 (1998).
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Loeb J. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocrine" Rev 4,378–388 (1983).
   Google Scholar
• Whybrow PC, Prange AJ, Jr. A hypothesis of thyroid-catecholaime-receptor interaction. Anii. Gen. Psychiatry 38,106–113 (1981).
   Google Scholar
• Dratman MB, Gordon JT. Thyroid hormones as neurotransmitters. Thyroid 6, 639–647 (1996).
   PubMed Web of Science ®Google Scholar
• Kirkegaard C, Faber J. The role of thyroid hormones in depression. Eur I Endocrine" 138,1–9 (1998).
   Google Scholar
• ••This paper provides a good review of therole of thyroid hormones in depression and their effect on the CNS.
   Google Scholar
• Sandrini M, Vitale G, Vergoni AV, OttaniA, Bertolini A. Effect of acute and chronic treatment with triiodothyroinine on serotonine levels and serotoninergic receptor subtypes in the rat brain. Life Scl. 58,1551–1559 (1996).
   Google Scholar
• Upadhyaya I, Agrawal JK, Dubey GP, Udupa KN. Biogenic amines and thyrotoxicosis. Acta Endocrinol 126,315–318 (1992).
   PubMedGoogle Scholar
• Cleare AJ, McGregor A, O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Gun. Endocrinol 43,713–719 (1995).
   Google Scholar
• Rastogi RB, Singhal RL. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for noradrenaline, dopamine and 5-hydroxytryptamine in rat brain. Phalmacol Exp. Ther. 198,609-618 (1976).
   Google Scholar
• Atterwill CK. Effect of acute and chronic triiothyrodine (T3) administration to rats on central 5-HT and dopamine-mediated behavioral responses and related brain biochemistry. Neurophatmacology20, 131–144 (1981).
   PubMedGoogle Scholar
• Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl. I Med. 340, 424–429 (1999).
   PubMed Web of Science ®Google Scholar
• Prange AJ. Novel uses of thyroid hormones in patients with affective disorders. Thyroid 6,537–543 (1996).
   PubMedGoogle Scholar
• Cooke RG, Joffe RT, Levitt AJ. T3 augmentation of antidepressant treatment in T4-replaced thyroid patients. j Gun. PFchiatry53, 16–18 (1992).
   Google Scholar
• Oppenheimer JH, Braverman LE, Toff A, Jackson IM, Ladenson PW. A therapeutic controversy. Thyroid hormone treatment: when and what?' Gun. Endocrinol Metab. 80,2873-2883 (1995).
   Google Scholar
• •This article provides a good review about the use of T3 VOMIT T4 in the treatment of depressive patients (controversy).
   Google Scholar
• Birkenhager TK, Vegt M, Nolen WA. An open study of triiodotyronine augmentation of tricyclic antidepressants in patients with refractory depression. Pharmacopsychiatry30, 23–26 (1997).
   Google Scholar
• Sokolov ST, Levitt AJ, Joffe RT. Thyroid hormone levels before unsuccessful antidepressant therapy are associated with later response to T3 augmentation. Psychiatry Res. 69,203-206 (1997).
   Google Scholar
• Schweitzer I, Tuckwell V, Johnson G. A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician. Aust. NZI Psychiatry31, 340–352 (1997).
   Google Scholar
• Irwin R, Ellis P, Delahunt J. Psychosis following acute alteration of thyroid status. Aust. NZI. Psychiatry 31,762–764 (1997).
   Google Scholar
• Rosser R. Thyrotoxicosis and lithium. BE Psychiatry 128,61–66 (1976).
   PubMedGoogle Scholar
• Turner JG, Brownlie BM Rogers TGH. Lithium as an adjunct radioiodine to therapy for thyrotoxicosis. Lancet 1,614–615 (1976).
   PubMedGoogle Scholar
• Weiner ME. Haloperidol, hyperthyroidism and sudden death. Am. j Rychiatry 136, 717–718 (1979).
   PubMedGoogle Scholar
• Hoffman WH, Chodoroff G, Piggott LB. Haloperidol and thyroid storm. Am. Psychiatry35, 484–486 (1978).
   Google Scholar
• Benvenga S, Lakshmanan M, Trimarchi E Carnitine is a natural occurring inhibitor of thyroid hormone nuclear uptake. Thyroid 10,1043–1050 (2000).
   PubMedGoogle Scholar
• Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi E Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized, double-blind, placebo-controlled clinical trial. .1. Gun. Endocrinol Metab. 86,3579-3594 (2001).
   Google Scholar
• Kragie L, Doyle D. Benzodiazepines inhibit temperature-dependent L-02511 triiodothyronine accumulation into human liver, human neuroblast and rat pituitary cell lines. Endocrinology130,1211–1216 (1992).
   PubMedGoogle Scholar
• Benvenga S. Benzodiazepine and remission of Graves disease. Thyroid 6,659–660 (1996).
   PubMedGoogle Scholar
• Duprez L, Parma J, Van Sande J et al Germline mutations in the thyrrotropin receptor gene cause non-autoimmune autosomal dominat hyperthyroidism. Nat. Genet. 7,396–401 (1994).
   PubMed Web of Science ®Google Scholar
• Alberti L, Proverbio MC, Costagliola S et al A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur j Endocrinol 145, 249–254 (2001).
   PubMedGoogle Scholar
• Kopp P. The TSH receptor and its role in thyroid disease. Cell Mal Life Sri. 58, 1301–1322 (2001).
   PubMedGoogle Scholar
• Koh LD, Napolitano G, Singer DS et al. Graves' disease: a host defense mechanism gone awry. Int. Rev. Iminunol 19,633–664 (2000).
   PubMedGoogle Scholar
• Bockmann J, Winter C, Wittkowski W Kreutz MR, Bockers TM. Cloning and expression of a brain-derived TSH receptor. Biochem. Biophys. Res. Commun. 238,173–178 (1997).
   PubMedGoogle Scholar
• Anderson GW. Thyroid hormones and the brain (Comentary). Front Neuroendocrinol 22,1–17 (2001).
   PubMed Web of Science ®Google Scholar
• •This article provides an overview of the molecular basis of thyroid hormone action followed by three sections detailing thyroid hormone regulation of brain development.
   Google Scholar